CellPoint B.V. – CAR-T therapies at the point-of-care

CAR-T TREATMENTS
AT THE HOSPITAL

Designing unconventional CAR-T Cells for all patients

Aming for wide access to CAR-T at clinical centers of excellence

manufacturing
at the
point-of-care

Provide CAR-T treatment within 1 week by

Treatment in one week, no complex logistics and
driving down costs

full training
and support of
clinicAl TEAMs

Clinical centers of excellence

Compliance to ensure quality and patient safety

MONITORING
CAR-T TREATMENT
WORKFLOW

NOVEl TECHNOLOGY

Intuitive dashboards supporting real-time monitoring

Engineering
T-cells for patients
in need

CellPoint enables clinicians to treat cancer by retargeting patient immune cells at the point-of-care.

SHORT VEIN TO VEIN

Treat when needed with a turnaround time of 1 week

available & affordable

Efficient and fully scalable

LOCAL MANUFACTURING

Closed and automated processing without complex logistics

REAL TIME MONITORING

Secure online platform for real-time control

OUR VISION

disrupt
time-to-treatment
and costs

Affordable and widely available

CellPoint has been founded to provide affordable and readily available CAR-T treatments for all patients in need. We focus on quality and patient safety, while driving down the time-to-treatment and costs by automation at the point-of-care.

Proud to present our

collaborations & partners

CLINICAL CENTERS OF EXCELLENCE

Cellpoint
Point of Care
locations

Hospitals have been selected across EU and US based on excellent clinical teams and facilities to deliver CAR-T treatments

Central supplies, quality assurance, and support by CellPoint staff

QUICK FACTS